Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 2 ( April-June, 2016 ) > List of Articles

RESEARCH ARTICLE

Renovascular Hypertension

Vijay Kher, Ashish Nandwani

Citation Information : Kher V, Nandwani A. Renovascular Hypertension. Hypertens J 2016; 2 (2):86-95.

DOI: 10.5005/jp-journals-10043-0037

Published Online: 00-06-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Nandwani A, Kher V. Renovascular Hypertension. Hypertens J 2016;2(2):86-95.


PDF Share
  1. Resistant hypertension: diagnosis, evaluation, and treatment: a scien-tific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008 Jun;51(6):1403-1419.
  2. Common secondary causes of resistant hypertension and rational for treatment. Int J Hypertens 2011;2011:236-239.
  3. Apparent prevalence of curable hypertension in the Hyper-tension Detection and Follow-up Program. Arch Intern Med 1985 Mar;145(3):424-427.
  4. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co prevalence. Clin Res Cardiol 2010 Aug;99(8):499-506.
  5. Renovascular hypertension and ischemic nephropathy. Am J Hypertens 2010 Nov;23(11):1159-1169.
  6. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 1979 Dec 6;301(23):1273-1276.
  7. Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients. J Vasc Surg 1994 Jul;20(1):1-5.
  8. Similar prevalence of renovascular hypertension in selected blacks and whites. Hypertension 1991 May;17(5):678-683.
  9. The rational clinical examination. Is listening for abdominal bruits useful in the evaluation of hypertension? JAMA 1995 Oct 25;274(16):1299-1301.
  10. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J 2011 Sep;32(18):2231-2235.
  11. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Asso-ciation Task Force on Practice Guidelines. J Am Coll Cardiol 2011 Nov 1;58(19):2020-2045.
  12. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization and prognosis. Kidney Int 2005 Jul;68(1):293-301.
  13. Atherosclerotic renovascular disease in United States. Kidney Int 2010 Jan;77(1):37-43.
  14. Prevalence of renal artery stenosis requiring revascular-ization in patients initially referred for coronary angiography. Catheter Cardiovasc Interv 2003 Mar;58(3):400-403.
  15. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens 2009 Jul;27(7):1333-1340.
  16. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 1995 Jul;48(1):171-176.
  17. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis-clinical and histopathology. Nephrol Dial Transplant 2010 Nov;25(11):3615-3622.
  18. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012 Jun 26;125(25):3182-3190.
  19. Fibromuscular dys-plasia. Orphanet J Rare Dis 2007 Jun 7;2:28.
  20. Fibromus-cular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014 Mar;129(9):1048-1078.
  21. Fibromuscular disease of renal artery: a new histopathologi-cal classification. Ann Vasc Surg 1992 May;6(3):220-224.
  22. Progression of renal artery fibromuscular dys-plasia in 42 patients as seen on angiography. Radiology 1982 Jan;142(1):252-253.
  23. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 2011 Mar;53(3):826-836.
  24. Fibromuscular dysplasia. N Engl J Med 2004 Apr 29;350(18):1862-1871.
  25. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest 2012 Mar;42(3):338-347.
  26. Coarctation of aorta from fetus to adult: curable condition or life long disease process? Heart 2005 Nov;91(11):1495-1502.
  27. Hyper-tension and coarctation of aorta: an inevitable consequence of developmental pathophysiology. Hypertens Res 2011 May;34(5):543-547.
  28. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 1988 Oct;12(4):964-972.
  29. Diagnostic criteria for Takayasu arteritis. Int J Cardiol 1996 Aug;(Suppl 54):S141-S147.
  30. Takayasu disease: a review. Cardiol Young 2008 Jun;18(3):250-259.
  31. Presentation and revascularization outcome in patients with radiation induced renal artery stenosis. Am J Kidney Dis 2001 Aug;38(2):302-309.
  32. Pathophysiology of renovascular hypertension. Hypertension 1991 May;17(5):707-719.
  33. Unraveling the mystery of Goldblatt hypertension. News Physiol Sci 1998 Aug;13:170-176.
  34. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin angiotensin system. J Clin Invest 2005 Apr;115(4):1092-1099.
  35. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery ste-nosis: paired and unpaired analysis. Am J Roentgenol 2007 Mar;188(3):798-811.
  36. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001 Feb;344(6):410-417.
  37. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 2005 Oct;46(4):603-609.
  38. Doppler sonography in renal artery stenosis –does the Resistive Index predict the success of intervention? Nephrol Dial Transplant 2007 Mar;22(3):692-696.
  39. Clinical utility of the resistive index in ath-erosclerotic renovascular disease. J Vasc Surg 2009 Jan;49(1):148-155.
  40. Renal MR and CT angiography: current concepts. Abdomen Imaging 2007 Jun;32(3):407-420.
  41. Minimally invasive diag-nosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int 1995 Oct;48(4):1332-1337.
  42. Accuracy of computed tomographic angiography and mag-netic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004 Nov 2;141(9):674-682.
  43. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991 Sep;18(3):289-298.
  44. Detection of renovascular hyper-tension. State of the art: 1992. Ann Intern Med 1992 Nov 15;117(10):845-853.
  45. Curable renal hypertension: renin, marker or cause? Question answered. Am J Hypertens 2014 Aug;27(8):1000-1003.
  46. Renal vein renin measurements accurately iden-tify renovascular hypertension caused by total occlusion of the renal artery. J Hypertens 2002 May;20(5):975-984.
  47. Current concepts in the management of renovas-cular hypertension and ischemic renal failure. Am J Kidney Dis 1989 Jun;13(6 Suppl 1):33-37.
  48. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008 Sep;156(3):549-555.
  49. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990 Dec;1(6):845-858.
  50. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant 2012 Apr;27(4):1403-1409.
  51. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014 Jan;370(1):13-22.
  52. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009 Nov 12;361(20):1953-1962.
  53. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009 Jun 16;150(12):840-848.
  54. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis. Cochrane Database Syst Rev 2014;(12):CD002944.
  55. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of ran-domized controlled trials. Am Heart J 2011 Mar;161(3):622-630.
  56. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000 Apr 6;342(14):1007-1014.
  57. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998 Mar;31(3):823-829.
  58. Randomized comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998 May;12(5):329-335.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.